Impact of Diabetes on Outcomes of Sorafenib Therapy for Hepatocellular Carcinoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of Diabetes on Outcomes of Sorafenib Therapy for Hepatocellular Carcinoma
Authors
Keywords
Overall Survival, Metformin, Sorafenib, Acarbose, Oral Hypoglycemic Agent
Journal
Targeted Oncology
Volume 12, Issue 1, Pages 61-67
Publisher
Springer Nature
Online
2016-08-09
DOI
10.1007/s11523-016-0454-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of metformin on clinical outcome in diabetic patients with advanced HCC receiving sorafenib
- (2015) Andrea Casadei Gardini et al. EXPERT OPINION ON PHARMACOTHERAPY
- Immune-mediated antitumor effect by type 2 diabetes drug, metformin
- (2015) Shingo Eikawa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- 2. Classification and Diagnosis of Diabetes
- (2014) DIABETES CARE
- The Association Between Metabolic Syndrome and Hepatocellular Carcinoma
- (2013) Raxitkumar Jinjuvadia et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- The effect of sorafenib treatment on the diabetic status of patients with renal cell or hepatocellular carcinoma
- (2012) Ilaria Imarisio et al. Future Oncology
- Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis
- (2012) Hiroshi Noto et al. PLoS One
- Metformin: An Emerging New Therapeutic Option for Targeting Cancer Stem Cells and Metastasis
- (2012) Ramandeep Rattan et al. Journal of Oncology
- Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1
- (2011) I. Ben Sahra et al. CANCER RESEARCH
- Metformin Amplifies Chemotherapy-Induced AMPK Activation and Antitumoral Growth
- (2011) G. Z. Rocha et al. CLINICAL CANCER RESEARCH
- Metformin as an antitumor agent in cancer prevention and treatment
- (2011) Donghui LI Journal of Diabetes
- Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma
- (2010) Manal M. Hassan et al. CANCER
- The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
- (2010) Mustafa S. Ascha et al. HEPATOLOGY
- Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug?
- (2010) I. Ben Sahra et al. MOLECULAR CANCER THERAPEUTICS
- Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
- (2010) Riccardo Lencioni et al. SEMINARS IN LIVER DISEASE
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease
- (2009) Valter Donadon et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now